CRISPR

CRISPR1-pex5

ID
ZDB-CRISPR-240412-1
Name
CRISPR1-pex5
Previous Names
None
Target
Sequence
5' - AATCCCCTCATGAAACTGAC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The PAM site was "TGG" at the 3' end.
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
wk5 pex5
Expression
Gene expression in Wild Types + CRISPR1-pex5
No data available
Phenotype
Phenotype resulting from CRISPR1-pex5
No data available
Phenotype of all Fish created by or utilizing CRISPR1-pex5
Phenotype Fish Conditions Figures
swim bladder uninflated, abnormal pex5wk5/wk5 fasting Fig. 2 with image from Bhandari et al., 2023
liver lipid increased amount, abnormal pex5wk5/wk5 standard conditions Fig. 1 with image from Bhandari et al., 2023
liver reactive oxygen species amount, ameliorated pex5wk5/wk5 chemical treatment by environment: N-acetyl-L-cysteine, fasting Fig. 4 with image from Bhandari et al., 2023
whole organism dead, abnormal pex5wk5/wk5 standard conditions Fig. 1 with image from Bhandari et al., 2023
whole organism decreased life span, exacerbated pex5wk5/wk5 fasting Fig. 2 with image from Bhandari et al., 2023
whole organism decreased life span, abnormal pex5wk5/wk5 standard conditions Fig. 1 with image from Bhandari et al., 2023
liver hypotrophic, abnormal pex5wk5/wk5 fasting Fig. 2 with image from Bhandari et al., 2023
liver apoptotic process occurrence, ameliorated pex5wk5/wk5 chemical treatment by environment: N-acetyl-L-cysteine, fasting Fig. 4 with image from Bhandari et al., 2023
liver apoptotic process increased occurrence, abnormal pex5wk5/wk5 fasting Fig. 4 with image from Bhandari et al., 2023
liver reactive oxygen species increased amount, abnormal pex5wk5/wk5 fasting Fig. 4 with image from Bhandari et al., 2023
pleuroperitoneal cavity edematous, abnormal pex5wk5/wk5 fasting Fig. 2 with image from Bhandari et al., 2023
nervous system myelination decreased occurrence, abnormal pex5wk5/wk5; ck1Tg standard conditions Fig. 1 with image from Bhandari et al., 2023
liver mitochondrion broken, abnormal pex5wk5/wk5; cms1Tg fasting Fig. 3 with image from Bhandari et al., 2023
liver mitochondrion morphology, abnormal pex5wk5/wk5; cms1Tg fasting Fig. 3 with image from Bhandari et al., 2023
liver mitochondrion morphology, abnormal pex5wk5/wk5; cms1Tg standard conditions Fig. 1 with image from Bhandari et al., 2023
liver mitochondrion increased amount, abnormal pex5wk5/wk5; cms1Tg fasting Fig. 3 with image from Bhandari et al., 2023
liver mitochondrion size, abnormal pex5wk5/wk5; cms1Tg standard conditions Fig. 1 with image from Bhandari et al., 2023
hepatocyte peroxisome decreased amount, abnormal pex5wk5/wk5; wk2Tg fasting Fig. 2 with image from Bhandari et al., 2023
hepatocyte peroxisome RFP expression spatial pattern, abnormal pex5wk5/wk5; wk2Tg standard conditions Fig. 1 with image from Bhandari et al., 2023
liver peroxisome decreased amount, abnormal pex5wk5/wk5; wk2Tg standard conditions Fig. 1 with image from Bhandari et al., 2023
Citations